Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease

E. Thomas; A. Wade; G. Crawford; B. Jenner; N. Levinson; J. Wilkinson

doi:10.1111/apt.12640

Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12640 ◽

2014 ◽

Vol 39 (6) ◽

pp. 595-602 ◽

Cited By ~ 40

Author(s):

E. Thomas ◽

A. Wade ◽

G. Crawford ◽

B. Jenner ◽

N. Levinson ◽

...

Keyword(s):

Clinical Trial ◽

Pilot Study ◽

Reflux Disease ◽

Gastrointestinal Symptoms ◽

Randomised Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Upper Gastrointestinal Symptoms ◽

Acid Pocket ◽

Upper Gastrointestinal

Download Full-text

Retracted: Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13334 ◽

2015 ◽

Vol 42 (7) ◽

pp. 845-854 ◽

Cited By ~ 20

Author(s):

J. Sun ◽

C. Yang ◽

H. Zhao ◽

P. Zheng ◽

J. Wilkinson ◽

...

Keyword(s):

Clinical Trial ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Clinical Efficacy ◽

Reflux Disease ◽

Gastrointestinal Symptoms ◽

Randomised Clinical Trial ◽

Efficacy And Safety ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.15018 ◽

2018 ◽

Vol 48 (9) ◽

pp. 1039-1039

Keyword(s):

Clinical Trial ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Clinical Efficacy ◽

Reflux Disease ◽

Gastrointestinal Symptoms ◽

Randomised Clinical Trial ◽

Efficacy And Safety ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Cited By ~ 22

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study

Digestive Diseases and Sciences ◽

10.1007/bf01535938 ◽

1988 ◽

Vol 33 (12) ◽

pp. 1505-1511 ◽

Cited By ~ 70

Author(s):

Richard H. Davis ◽

Mary H. Clench ◽

John R. Mathias

Keyword(s):

Gastrointestinal Symptoms ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms, a randomised clinical trial

Gastroenterology ◽

10.1016/s0016-5085(03)82589-1 ◽

2003 ◽

Vol 124 (4) ◽

pp. A511

Author(s):

Robert J.F. Laheij ◽

Leo G.M. Van Rossum ◽

Jan B.M. Jansen ◽

Freek W.A. Verheught

Keyword(s):

Clinical Trial ◽

Proton Pump Inhibitor ◽

Acetylsalicylic Acid ◽

Proton Pump ◽

Gastrointestinal Symptoms ◽

Randomised Clinical Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04517.x ◽

2010 ◽

Vol 33 (3) ◽

pp. 323-332 ◽

Cited By ~ 42

Author(s):

H. Miwa ◽

K. Inoue ◽

K. Ashida ◽

T. Kogawa ◽

A. Nagahara ◽

...

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mosapride Citrate

Download Full-text

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

Gut ◽

10.1136/gut.49.3.395 ◽

2001 ◽

Vol 49 (3) ◽

pp. 395-401 ◽

Cited By ~ 124

Author(s):

N J Talley

Keyword(s):

Diabetes Mellitus ◽

Receptor Agonist ◽

Controlled Trial ◽

Gastrointestinal Symptoms ◽

Double Blind ◽

Double Blind Placebo ◽

Upper Gastrointestinal Symptoms ◽

Motilin Receptor ◽

Upper Gastrointestinal

Download Full-text

Can Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) Relieve Upper Gastrointestinal Symptoms in Gastro-oesophageal Reflux Disease?

Korean Journal of Gastroenterology ◽

10.4166/kjg.2014.63.6.386 ◽

2014 ◽

Vol 63 (6) ◽

pp. 386

Author(s):

Sung Eun Kim ◽

Moo In Park

Keyword(s):

Reflux Disease ◽

Gastrointestinal Symptoms ◽

Oesophageal Reflux ◽

Oesophageal Reflux Disease ◽

Upper Gastrointestinal Symptoms ◽

Acid Pocket ◽

Upper Gastrointestinal

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms

Esophagus ◽

10.1007/s10388-020-00801-1 ◽

2021 ◽

Author(s):

Kimio Isshi ◽

Hiroto Furuhashi ◽

Akio Koizumi ◽

Koji Nakada

Keyword(s):

Quality Of Life ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Reflux Disease ◽

Daily Life ◽

Gastrointestinal Symptoms ◽

Disease Symptoms ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text